 |
 |

The IDEAL Cholesterol
Lower Is Better
Christopher P. Cannon, MD
JAMA. 2005;294:2492-2494.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Three decades ago, the primary results of the Multiple Risk Factor Intervention Trial (MRFIT) were published in JAMA; that trial attempted to demonstrate benefits from lowering cholesterol (with diet) and managing other known risk factors for reducing cardiovascular morbidity and mortality.1 Since then, multiple trials have shown cardiovascular benefit from lowering cholesterol, especially low-density lipoprotein cholesterol (LDL-C).2-3 However, as of 1993, no trial had demonstrated a clear reduction in total mortality and, thus, debate still raged as to whether it was beneficial to reduce cholesterol.3
This changed when Pedersen and colleagues4 reported the landmark Scandinavian Simvastatin Survival Study (4S), which demonstrated that use of simvastatin, 20 to 40 mg/d, produced a highly significant 30% reduction in total mortality, in addition to reductions in myocardial infarction (MI) and the need for coronary revascularization. Subsequent trials expanded the benefit of treating broader groups of patients with statins,5 . . . [Full Text of this Article]
Author Affiliations: TIMI Study Group, Cardiovascular Division, Brigham and Womens Hospital and Harvard Medical School, Boston, Mass.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED LETTERS
Statins, Diet, and Low Cholesterol
Dario Giugliano and Katherine Esposito
JAMA. 2006;295(21):2479.
EXTRACT
| FULL TEXT
Statins, Diet, and Low Cholesterol
Rohit Arora and Saravanan Balamuthusamy
JAMA. 2006;295(21):2479.
EXTRACT
| FULL TEXT
Statins, Diet, and Low CholesterolReply
Christopher P. Cannon
JAMA. 2006;295(21):2479-2480.
EXTRACT
| FULL TEXT
Low-Carbohydrate Diet and Blood Lipid Levels: How Good and How Fast?
Dario Giugliano, Maria Ida Maiorino, and Katherine Esposito
Arch Intern Med. 2009;169(20):1930.
EXTRACT
| FULL TEXT
RELATED ARTICLE
High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction: The IDEAL Study: A Randomized Controlled Trial
Terje R. Pedersen, Ole Faergeman, John J. P. Kastelein, Anders G. Olsson, Matti J. Tikkanen, Ingar Holme, Mogens Lytken Larsen, Fredrik S. Bendiksen, Christina Lindahl, Michael Szarek, John Tsai, and for the Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group
JAMA. 2005;294(19):2437-2445.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Low-Carbohydrate Diet and Blood Lipid Levels: How Good and How Fast?
Giugliano et al.
Arch Intern Med 2009;169:1930-1930.
FULL TEXT
Intensity of Statin Therapy in Relation to Myocardial Ischemia, Troponin T Release, and Clinical Cardiac Outcome in Patients Undergoing Major Vascular Surgery
Feringa et al.
J Am Coll Cardiol 2007;50:1649-1656.
ABSTRACT
| FULL TEXT
Biases in the Identification of Risk Factor Thresholds and J-Curves
Marschner et al.
Am J Epidemiol 2007;166:824-831.
ABSTRACT
| FULL TEXT
Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis
Qian et al.
J. Lipid Res. 2007;48:1488-1498.
ABSTRACT
| FULL TEXT
The gap between theory and practice: what do the trials tell us?
Pedersen
Eur Heart J Suppl 2006;8:F10-F16.
ABSTRACT
| FULL TEXT
Reducing risk by raising HDL-cholesterol: the evidence
Drexel
Eur Heart J Suppl 2006;8:F23-F29.
ABSTRACT
| FULL TEXT
Statins, diet, and low cholesterol.
Giugliano and Esposito
JAMA 2006;295:2479-2479.
FULL TEXT
Statins, diet, and low cholesterol.
Arora and Balamuthusamy
JAMA 2006;295:2479-2479.
FULL TEXT
The Changing Face of Dyslipidemia Therapies
Rochester and Cooke
Journal of Pharmacy Practice 2006;19:79-93.
ABSTRACT
Coronary Artery Calcium: Should We Rely on This Surrogate Marker?
Redberg
Circulation 2006;113:336-337.
FULL TEXT
Intensive LDL Lowering After MI
Journal Watch Cardiology 2005;2005:1-1.
FULL TEXT
|